---
title: <sup>19</sup>Fluorine-MRI Based Longitudinal Immuno-Microenvironment-Monitoring
  for Pancreatic Cancer
date: '2024-08-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39189434/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240827181517&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: Pancreatic cancer has a poor prognosis. Targeting Kirsten
  Rat Sarcoma (KRAS) mutation and its related pathways may enhance immunotherapy efficacy.
  While in vivo monitoring of therapeutic response and immune cell migration remains
  challenging, Fluorine-19 MRI (^(19)F MRI) may allow noninvasive longitudinal imaging
  of immune ...'
disable_comments: true
---
BACKGROUND: Pancreatic cancer has a poor prognosis. Targeting Kirsten Rat Sarcoma (KRAS) mutation and its related pathways may enhance immunotherapy efficacy. While in vivo monitoring of therapeutic response and immune cell migration remains challenging, Fluorine-19 MRI (^(19)F MRI) may allow noninvasive longitudinal imaging of immune ...